Format

Send to:

Choose Destination
See comment in PubMed Commons below
World J Gastroenterol. 2011 Jan 7;17(1):69-78. doi: 10.3748/wjg.v17.i1.69.

S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer.

Author information

  • 1Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

Abstract

AIM:

To develop lymph node metastasis (LNM)-associated biomarkers for colorectal cancer (CRC) using quantitative proteome analysis.

METHODS:

Differences in protein expression between primary CRC with LNM (LNM CRC) and without LNM (non-LNM CRC) were assessed using methyl esterification stable isotope labeling coupled with 2D liquid chromatography followed by tandem mass spectrometry (2D-LC-MS/MS). The relationship to clinicopathological parameters and prognosis of candidate biomarkers was examined using an independent sample set.

RESULTS:

Forty-three proteins were found to be differentially expressed by at least 2.5-fold in two types of CRC. S100A4 was significantly upregulated in LNM CRC compared with non-LNM CRC, which was confirmed by Western blotting, immunohistochemistry and real-time quantitative polymerase chain reaction. Further immunohistochemistry on another 112 CRC cases showed that overexpression of S100A4 frequently existed in LNM CRC compared with non-LNM CRC (P<0.001). Overexpression of S100A4 was significantly associated with LNM (P<0.001), advanced TNM stage (P<0.001), increased 5-year recurrence rate (P<0.001) and decreased 5-year overall survival rate (P<0.001). Univariate and multivariate analyses indicated that S100A4 expression was an independent prognostic factor for recurrence and survival of CRC patients (P<0.05).

CONCLUSION:

S100A4 might serve as a powerful biomarker for LNM and a prognostic factor in CRC.

KEYWORDS:

Colorectal cancer; Lymph node metastasis; Prognosis; Proteome analysis; S100A4

PMID:
21218086
[PubMed - indexed for MEDLINE]
PMCID:
PMC3016682
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Baishideng Publishing Group Inc. Icon for PubMed Central
    Loading ...
    Write to the Help Desk